These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14733421)

  • 1. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis.
    Griethe W; Schmitt R; Jurgensen JS; Bachmann S; Eckardt KU; Schindler R
    J Nephrol; 2003; 16(5):728-32. PubMed ID: 14733421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
    Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis.
    Nigwekar SU; Jiramongkolchai P; Wunderer F; Bloch E; Ichinose R; Nazarian RM; Thadhani RI; Malhotra R; Bloch DB
    Am J Nephrol; 2017; 46(5):429-438. PubMed ID: 29130990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous necrosis by calcific uremic arteriolopathy.
    Galimberti RL; Farias Edos R; Parra IH; Algranati L; Kowalczuk A; Imperiali N; Greloni GC; Galimberti G
    Int J Dermatol; 2005 Feb; 44(2):101-6. PubMed ID: 15689205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy.
    Kramann R; Brandenburg VM; Schurgers LJ; Ketteler M; Westphal S; Leisten I; Bovi M; Jahnen-Dechent W; Knüchel R; Floege J; Schneider RK
    Nephrol Dial Transplant; 2013 Apr; 28(4):856-68. PubMed ID: 23223222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats.
    Oğütmen B; Tuğlular S; Cakalağaoğlu F; Ozener C; Akoğlu E
    Transplant Proc; 2006 Mar; 38(2):487-9. PubMed ID: 16549155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study.
    Canfield AE; Farrington C; Dziobon MD; Boot-Handford RP; Heagerty AM; Kumar SN; Roberts IS
    J Pathol; 2002 Feb; 196(2):228-34. PubMed ID: 11793375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciphylaxis: a rare limb and life threatening cause of ischaemic skin necrosis and ulceration.
    Edwards RB; Jaffe W; Arrowsmith J; Henderson HP
    Br J Plast Surg; 2000 Apr; 53(3):253-5. PubMed ID: 10738337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins in vascular calcification.
    Hruska KA; Mathew S; Saab G
    Circ Res; 2005 Jul; 97(2):105-14. PubMed ID: 16037577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of calciphylaxis in chronic renal failure].
    Watanabe M; Yamaguchi S; Osanai H; Murakami M
    Hinyokika Kiyo; 2010 Oct; 56(10):597-600. PubMed ID: 21063168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcific uremic arteriolopathy: advances in pathogenesis and treatment.
    Rogers NM; Teubner DJ; Coates PT
    Semin Dial; 2007; 20(2):150-7. PubMed ID: 17374090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionable specificity of histologic findings in calcific uremic arteriolopathy.
    Ellis CL; O'Neill WC
    Kidney Int; 2018 Aug; 94(2):390-395. PubMed ID: 29885932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous calciphylaxis. An underrecognized clinicopathologic entity.
    Essary LR; Wick MR
    Am J Clin Pathol; 2000 Feb; 113(2):280-7. PubMed ID: 10664631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis.
    Chang K; Weiss D; Suo J; Vega JD; Giddens D; Taylor WR; Jo H
    Circulation; 2007 Sep; 116(11):1258-66. PubMed ID: 17785623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells: role of shear stress and the cAMP/protein kinase A pathway.
    Csiszar A; Labinskyy N; Smith KE; Rivera A; Bakker EN; Jo H; Gardner J; Orosz Z; Ungvari Z
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):776-82. PubMed ID: 17272757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse dermal angiomatosis associated with calciphylaxis.
    Prinz Vavricka BM; Barry C; Victor T; Guitart J
    Am J Dermatopathol; 2009 Oct; 31(7):653-7. PubMed ID: 19652584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin expression in biopsies of calciphylaxis.
    Magro CM; Momtahen S; Hagen JW
    Eur J Dermatol; 2015; 25(1):20-5. PubMed ID: 25847841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant pulmonary calciphylaxis and metastatic calcification causing acute respiratory failure in a uremic patient.
    Li YJ; Tian YC; Chen YC; Huang SF; Huang CC; Fang JT; Yang CW
    Am J Kidney Dis; 2006 Apr; 47(4):e47-53. PubMed ID: 16564932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic calciphylaxis and acquired perforating disease in a uremic patient].
    Asensio Sánchez MJ; Del Pozo Hernando LJ; Martínez Díaz A; Arnaiz Esteban JF
    Med Cutan Ibero Lat Am; 1990; 18(2):89-95. PubMed ID: 2214945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.